BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35843498)

  • 1. Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis.
    Skipper CP; Hullsiek KH; Cresswell FV; Tadeo KK; Okirwoth M; Blackstad M; Hernandez-Alvarado N; Fernández-Alarcón C; Walukaga S; Martyn E; Ellis J; Ssebambulidde K; Tugume L; Nuwagira E; Rhein J; Meya DB; Boulware DR; Schleiss MR;
    Int J Infect Dis; 2022 Sep; 122():785-792. PubMed ID: 35843498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.
    Skipper C; Schleiss MR; Bangdiwala AS; Hernandez-Alvarado N; Taseera K; Nabeta HW; Musubire AK; Lofgren SM; Wiesner DL; Rhein J; Rajasingham R; Schutz C; Meintjes G; Muzoora C; Meya DB; Boulware DR
    Clin Infect Dis; 2020 Jul; 71(3):525-531. PubMed ID: 31504335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV.
    Ellis J; Bangdiwala AS; Skipper CP; Tugume L; Nsangi L; Matovu J; Pastick KA; Ssebambulidde K; Morawski BM; Musubire AK; Schleiss MR; Moore DAJ; Jarvis JN; Boulware DR; Meya DB; Castelnuovo B
    Open Forum Infect Dis; 2023 Sep; 10(9):ofad449. PubMed ID: 37732168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.
    Fielding K; Koba A; Grant AD; Charalambous S; Day J; Spak C; Wald A; Huang ML; Corey L; Churchyard GJ
    PLoS One; 2011; 6(10):e25571. PubMed ID: 22022413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
    Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
    J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    Levi LI; Sharma S; Schleiss MR; Furrer H; Nixon DE; Blackstad M; Hernandez-Alvarado N; Dwyer DE; Borges AH; Lane HC; Lundgren J; Neaton JD; Molina JM;
    AIDS; 2022 Jul; 36(9):1265-1272. PubMed ID: 35442221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.
    Jarvis JN; Casazza JP; Stone HH; Meintjes G; Lawn SD; Levitz SM; Harrison TS; Koup RA
    J Infect Dis; 2013 Jun; 207(12):1817-28. PubMed ID: 23493728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study.
    Albasanz-Puig A; Suanzes P; Esperalba J; Fernández C; Sellarès-Nadal J; Torrella A; Planas B; Segura A; Burgos J; Ribera E; Cañas-Ruano E; García JN; Navarro J; Curran A; Len Ó; Falcó V
    HIV Med; 2021 Sep; 22(8):682-689. PubMed ID: 33998115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus viremia and advanced HIV disease: is there an argument for anti-CMV treatment?
    Skipper CP; Schleiss MR
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):227-233. PubMed ID: 36691835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital.
    Wamalwa D; Njuguna I; Maleche-Obimbo E; Begnel E; Chebet DJ; Onyango JA; Cranmer LM; Huang ML; Richardson BA; Boeckh M; John-Stewart G; Slyker J
    Clin Infect Dis; 2022 Apr; 74(7):1237-1246. PubMed ID: 34214163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants.
    Slyker JA; Lohman-Payne BL; Rowland-Jones SL; Otieno P; Maleche-Obimbo E; Richardson B; Farquhar C; Mbori-Ngacha D; Emery VC; John-Stewart GC
    AIDS; 2009 Jan; 23(1):117-24. PubMed ID: 19050393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    Moraka NO; Moyo S; Mayondi G; Leidner J; Ibrahim M; Smith C; Weinberg A; Li S; Thami PK; Kammerer B; Ajibola G; Musonda R; Shapiro R; Gaseitsiwe S; Lockman S
    J Acquir Immune Defic Syndr; 2019 May; 81(1):118-124. PubMed ID: 30964806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.
    Para MF; Kalish LA; Collier AC; Murphy EL; Drew WL;
    J Infect Dis; 2001 Jun; 183(11):1673-7. PubMed ID: 11343218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.